{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:26:00Z","timestamp":1792297560283,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.joca.2018.05.021","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T11:02:59Z","timestamp":1528455779000},"page":"1263-1273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review"],"prefix":"10.1016","volume":"26","author":[{"given":"K.","family":"Nakata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Take","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2018.05.021_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1759720X10378373","article-title":"The role of synovitis in osteoarthritis","volume":"2","author":"Wenham","year":"2010","journal-title":"Ther Adv Musculoskel Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jos.2016.01.004","article-title":"Limited efficacy of COX-2 inhibitors on nerve growth factor and metalloproteinases expressions in human synovial fibroblasts","volume":"21","author":"Yorifuji","year":"2016","journal-title":"J\u00a0Orthop Sci"},{"key":"10.1016\/j.joca.2018.05.021_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/s101650300001","article-title":"Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander","volume":"13","author":"Lajeunesse","year":"2003","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.joca.2018.05.021_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.joca.2018.05.021_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.joca.2018.05.021_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/ar3437","article-title":"Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis","volume":"13","author":"Zweers","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2018.05.021_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0049-0172(03)00134-3","article-title":"Cyclooxygenase-2 and prostaglandins in articular tissues","volume":"33","author":"Martel-Pelletier","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2018.05.021_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2018.05.021_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/annrheumdis-2012-201844","article-title":"NSAIDs and radiographic progression in ankylosing spondylitis bagging big game with small arms?","volume":"71","author":"Haroon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/rheumatology\/ken116","article-title":"Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast\u2013comparison to its effects on osteoarthritic chondrocytes","volume":"47","author":"Alvarez-Soria","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2018.05.021_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1359\/JBMR.051025","article-title":"Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II","volume":"21","author":"Katagiri","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.joca.2018.05.021_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.joca.2005.02.004","article-title":"Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in\u00a0vitro study","volume":"13","author":"Mastbergen","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2018.05.021_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001388","article-title":"Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries","volume":"10","author":"McGettigan","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.joca.2018.05.021_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar2655","article-title":"Developments in the scientific understanding of osteoarthritis","volume":"11","author":"Abramson","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2018.05.021_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)17544-3","article-title":"Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models","volume":"25","author":"Kawaguchi","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.joca.2018.05.021_bib17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI119280","article-title":"Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide","volume":"99","author":"Amin","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2018.05.021_bib18","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.181.7.5082","article-title":"Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor","volume":"181","author":"Attur","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.joca.2018.05.021_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2013.04.002","article-title":"Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib","volume":"152","author":"Dave","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1016\/j.joca.2018.05.021_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1254\/jphs.12016FP","article-title":"In\u00a0vitro effects of VA441, a new selective cyclooxygenase-2 inhibitor, on human osteoarthritic chondrocytes exposed to IL-1beta","volume":"120","author":"Fioravanti","year":"2012","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.joca.2018.05.021_bib21","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1021\/mp500026x","article-title":"A\u00a0three-dimensionally engineered biomimetic cartilaginous tissue model for osteoarthritic drug evaluation","volume":"11","author":"Peck","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.joca.2018.05.021_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.joca.2014.03.011","article-title":"Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress","volume":"22","author":"Su","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2018.05.021_bib23","first-page":"10902","article-title":"Celecoxib can suppress expression of genes associated with PGE2 pathway in chondrocytes under inflammatory conditions","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.joca.2018.05.021_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.colsurfb.2013.06.015","article-title":"Celecoxib-loaded PLGA\/cyclodextrin microspheres: characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures","volume":"111","author":"Cannava","year":"2013","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.joca.2018.05.021_bib25","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/ar2066","article-title":"Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal","volume":"8","author":"Shi","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2018.05.021_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.joca.2018.05.021_bib27","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/ar2926","article-title":"Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein\/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes","volume":"12","author":"Chen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2018.05.021_bib28","first-page":"99","article-title":"Activation of diverse eicosanoid pathways in osteoarthritic cartilage: a lipidomic and genomic analysis","volume":"70","author":"Attur","year":"2012","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib29","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO;2-I","article-title":"The osteoprotegerin\/receptor activator of nuclear factor kappaB\/receptor activator of nuclear factor kappaB ligand system in cartilage","volume":"44","author":"Komuro","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/art.27204","article-title":"Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis","volume":"62","author":"Moreno-Rubio","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/s10165-006-0490-6","article-title":"Cartilage destruction by matrix degradation products","volume":"16","author":"Yasuda","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.joca.2018.05.021_bib32","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10753-015-0131-3","article-title":"Celecoxib combined with diacerein effectively alleviates osteoarthritis in rats via regulating JNK and p38MAPK signaling pathways","volume":"38","author":"Li","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.joca.2018.05.021_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/rheumatology\/41.9.996","article-title":"Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats","volume":"41","author":"Larsson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2018.05.021_bib34","first-page":"10","article-title":"Comparative study of the effect of diacerein and diclofenac sodium and their combination in osteoarthritis model induced by monoiodoacetate in albino rats","volume":"6","author":"Osman","year":"2015","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"10.1016\/j.joca.2018.05.021_bib35","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2009.122002","article-title":"Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis","volume":"69","author":"Pelletier","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.phymed.2012.07.008","article-title":"Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in rats","volume":"19","author":"Ashkavand","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joca.2018.05.021_bib37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/oxfordjournals.jbchem.a022376","article-title":"Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1","volume":"125","author":"Fujisawa","year":"1999","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.joca.2018.05.021_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-9255-6-35","article-title":"Effects of hydrogen sulfide on inflammation in caerulein-induced acute pancreatitis","volume":"6","author":"Sidhapuriwala","year":"2009","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.joca.2018.05.021_bib39","first-page":"1537","article-title":"Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis","volume":"19","author":"Dief","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.joca.2018.05.021_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13618-015-0025-3","article-title":"The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis","volume":"5","author":"Herrera","year":"2015","journal-title":"Med Gas Res"},{"key":"10.1016\/j.joca.2018.05.021_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12272-013-0010-0","article-title":"Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis","volume":"36","author":"Moon","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.joca.2018.05.021_bib42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3109\/s10165-012-0772-0","article-title":"Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints","volume":"23","author":"Takahashi","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.joca.2018.05.021_bib43","doi-asserted-by":"crossref","first-page":"BR247","DOI":"10.12659\/MSM.882901","article-title":"Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte","volume":"18","author":"Ou","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.joca.2018.05.021_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.22203\/eCM.v022a31","article-title":"Inhibition of cyclooxygenase-2 impacts chondrocyte hypertrophic differentiation during endochondral ossification","volume":"22","author":"Welting","year":"2011","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.joca.2018.05.021_bib45","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.joca.2014.06.013","article-title":"Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: celecoxib may possess disease-modifying properties","volume":"22","author":"Panahifar","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2018.05.021_bib46","doi-asserted-by":"crossref","first-page":"595273","DOI":"10.1155\/2015\/595273","article-title":"Study of osteoarthritis treatment with anti-inflammatory drugs: cyclooxygenase-2 inhibitor and steroids","volume":"2015","author":"Cho","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.joca.2018.05.021_bib47","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00296-011-1978-8","article-title":"The effects of NSAIDs on types I, II, and III collagen metabolism in a rat osteoarthritis model","volume":"32","author":"Ou","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.joca.2018.05.021_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2012.11.031","article-title":"Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model","volume":"441","author":"Dong","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.joca.2018.05.021_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/art.33324","article-title":"Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice","volume":"64","author":"Fukai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03639045.2013.850704","article-title":"In\u00a0vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system","volume":"41","author":"Bedouet","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.joca.2018.05.021_bib51","first-page":"438","article-title":"Comparison of the effects of chronic intra-articular administration of tenoxicam, diclofenac, and methylprednisolone in healthy rats","volume":"49","author":"Orak","year":"2015","journal-title":"Acta Orthop Traumatol Turcica"},{"key":"10.1016\/j.joca.2018.05.021_bib52","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1002\/art.21373","article-title":"Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity","volume":"52","author":"Loeuille","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib53","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/ard.2004.025270","article-title":"Synovial tissue inflammation in early and late osteoarthritis","volume":"64","author":"Benito","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib54","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/ard.2005.046920","article-title":"Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac","volume":"65","author":"Alvarez-Soria","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jop.12045","article-title":"The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production","volume":"42","author":"Kawashima","year":"2013","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.joca.2018.05.021_bib56","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","article-title":"Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23","volume":"191","author":"Paulissen","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.joca.2018.05.021_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10787-014-0200-5","article-title":"Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1","volume":"22","author":"El-Sayed","year":"2014","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.joca.2018.05.021_bib58","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.3390\/ijms11104106","article-title":"Efficacy of intra-articular injection of celecoxib in a rabbit model of osteoarthritis","volume":"11","author":"Jiang","year":"2010","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joca.2018.05.021_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cbi.2015.04.021","article-title":"Protective effect of apigenin on Freund's complete adjuvant-induced arthritis in rats via inhibiting P2X7\/NF-kappaB pathway","volume":"236","author":"Chang","year":"2015","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.joca.2018.05.021_bib60","doi-asserted-by":"crossref","first-page":"505842","DOI":"10.1155\/2012\/505842","article-title":"A\u00a0synoviocyte model for osteoarthritis and rheumatoid arthritis: response to Ibuprofen, betamethasone, and ginger extract-a cross-sectional in\u00a0vitro study","volume":"2012","author":"Ribel-Madsen","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.joca.2018.05.021_bib61","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.joca.2013.06.026","article-title":"The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial","volume":"21","author":"Gallelli","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2018.05.021_bib62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/mmr.2012.1168","article-title":"Effects of exercise therapy on knee joint function and synovial fluid cytokine levels in patients with knee osteoarthritis","volume":"7","author":"Zhang","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.joca.2018.05.021_bib63","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.intimp.2011.04.003","article-title":"Antioxidant and anti-inflammatory effect of polysaccharides from Lobophora variegata on zymosan-induced arthritis in rats","volume":"11","author":"Paiva","year":"2011","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.joca.2018.05.021_bib64","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1002\/art.22921","article-title":"Role of subchondral bone in osteoarthritis development: a comparative study of two strains of Guinea pigs with and without spontaneously occurring osteoarthritis","volume":"56","author":"Muraoka","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib65","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jor.22937","article-title":"3-D localization of non-radioactive strontium in osteoarthritic bone: role in the dynamic labeling of bone pathological changes","volume":"33","author":"Panahifar","year":"2015","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.joca.2018.05.021_bib66","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jbm.a.33197","article-title":"Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor","volume":"99","author":"Geng","year":"2011","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.joca.2018.05.021_bib67","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/rheumatology\/kep300","article-title":"Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis","volume":"48","author":"Kwan Tat","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2018.05.021_bib68","first-page":"357","article-title":"Effects of diclofenac and celecoxib on osteoclastogenesis during alveolar bone healing, in\u00a0vivo","volume":"11","author":"Ghalayani","year":"2014","journal-title":"Dent Res J (Isfahan)"},{"key":"10.1016\/j.joca.2018.05.021_bib69","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0006-2952(01)00861-9","article-title":"Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in\u00a0vitro","volume":"63","author":"Igarashi","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.joca.2018.05.021_bib70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1756-185X.12076","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis","volume":"17","author":"Tsuji","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.joca.2018.05.021_bib71","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/03008200701541775","article-title":"Effect of compressive force on the production of prostaglandin E(2) and its receptors in osteoblastic Saos-2 cells","volume":"48","author":"Sanuki","year":"2007","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.joca.2018.05.021_bib72","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/03008200903168484","article-title":"Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells","volume":"51","author":"Sanuki","year":"2010","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.joca.2018.05.021_bib73","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.bbrc.2004.03.170","article-title":"Growth factor regulation of human growth plate chondrocyte proliferation in\u00a0vitro","volume":"317","author":"Olney","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.joca.2018.05.021_bib74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/en.2014-1348","article-title":"Prostacyclin regulates bone growth via the Epac\/Rap1 pathway","volume":"156","author":"Hutchison","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.joca.2018.05.021_bib75","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/926369","article-title":"The effect of cyclooxygenase inhibition on tendon-bone healing in an in\u00a0vitro coculture model","volume":"2015","author":"Schwarting","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.joca.2018.05.021_bib76","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1089\/scd.2009.0393","article-title":"The effects of COX-2 inhibitor during osteogenic differentiation of bone marrow-derived human mesenchymal stem cells","volume":"19","author":"Yoon","year":"2010","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.joca.2018.05.021_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.archoralbio.2010.10.018","article-title":"Effect of acetaminophen, ibuprofen and methylprednisolone on different parameters of human osteoblast-like cells","volume":"56","author":"Garcia-Martinez","year":"2011","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joca.2018.05.021_bib78","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1089\/ten.tea.2014.0668","article-title":"The effects of naproxen on chondrogenesis of human mesenchymal stem cells","volume":"21","author":"Antoniou","year":"2015","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.joca.2018.05.021_bib79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/CBI20090211","article-title":"Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells","volume":"35","author":"Muller","year":"2011","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.joca.2018.05.021_bib80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1582-4934.2010.01006.x","article-title":"NSAIDS inhibit in\u00a0vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man","volume":"15","author":"Pountos","year":"2011","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.joca.2018.05.021_bib81","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/0019-5413.114930","article-title":"Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats","volume":"47","author":"Li","year":"2013","journal-title":"Indian J Orthop"},{"key":"10.1016\/j.joca.2018.05.021_bib82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/08941939.2010.481009","article-title":"Short-term treatment with COX-2 inhibitors does not impair fracture healing","volume":"23","author":"Utvag","year":"2010","journal-title":"J\u00a0Invest Surg"},{"key":"10.1016\/j.joca.2018.05.021_bib83","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/CIA.S85225","article-title":"Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats","volume":"10","author":"Liu","year":"2015","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.joca.2018.05.021_bib84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.semarthrit.2009.10.003","article-title":"An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis","volume":"40","author":"Raynauld","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0972-124X.128216","article-title":"Comparative evaluation of the efficacy of the cyclooxygenase pathway inhibitor and nitric oxide synthase inhibitor in the reduction of alveolar bone loss in ligature induced periodontitis in rats: an experimental study","volume":"18","author":"Jagadish","year":"2014","journal-title":"J\u00a0Indian Soc Periodontol"},{"key":"10.1016\/j.joca.2018.05.021_bib86","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/jor.21044","article-title":"BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL\/6-mice","volume":"28","author":"Spiro","year":"2010","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.joca.2018.05.021_bib87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jor.22203","article-title":"Selective and non-selective cyclooxygenase inhibitors delay stress fracture healing in the rat ulna","volume":"31","author":"Kidd","year":"2013","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.joca.2018.05.021_bib88","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/art.1780350715","article-title":"Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy","volume":"35","author":"von der Mark","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2018.05.021_bib89","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/ten.tea.2012.0129","article-title":"Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells","volume":"19","author":"Almaawi","year":"2013","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.joca.2018.05.021_bib90","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/ten.tea.2014.0148","article-title":"Naproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenase","volume":"21","author":"Alaseem","year":"2015","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.joca.2018.05.021_bib91","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/ar4614","article-title":"Naproxen affects osteogenesis of human mesenchymal stem cells via regulation of Indian hedgehog signaling molecules","volume":"16","author":"Salem","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2018.05.021_bib92","first-page":"78","article-title":"Bone loss from high repetitive high force loading is prevented by ibuprofen treatment","volume":"14","author":"Jain","year":"2014","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.joca.2018.05.021_bib93","first-page":"691412","article-title":"Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder","volume":"2011","author":"Driban","year":"2011","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.joca.2018.05.021_bib94","first-page":"Cd009865","article-title":"Celecoxib for osteoarthritis","volume":"5","author":"Puljak","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.joca.2018.05.021_bib95","doi-asserted-by":"crossref","first-page":"e3585","DOI":"10.1097\/MD.0000000000003585","article-title":"Efficacy and safety of celecoxib therapy in osteoarthritis: a meta-analysis of randomized controlled trials","volume":"95","author":"Xu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.joca.2018.05.021_bib96","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1016\/j.joca.2017.02.725","article-title":"Lack of a clear disease modifying activity of celecoxib in treatment of end-stage knee osteoarthritis: a randomized observer blinded clinical trial","volume":"25","author":"van Helvoort","year":"2017","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458418313153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458418313153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:48:16Z","timestamp":1761018496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458418313153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":96,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1063458418313153"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2018.05.021","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2018.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}